Don't Eat the Marshmallow! 4 Tips for Financial Self-Control
Get the Lead Out: Lipsticks That Won't Hurt Your Pocketbook Or Your Health
Consumer Spending Forecast to Boost U.S. Economy
GM Shares Top Level Not Seen Since 2011
NASDAQ: SCLN
China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug
SciClone Pharmaceuticals, Inc. Reaches Neucardin Deal for Up to $40.5 Million With
Sciclone (SCLN) Enters Licensing Agreement with Neucardin in East Asia
SciClone, Zensun enter licensing agreement for Neucardin
SciClone sees Q1 EPS 7c, two estimates 9c
SciClone Reports Anticipated Financial Results for the First Quarter 2013
New Market Research Report: SciClone Pharmaceuticals, Inc. (SCLN) - Financial and Strategic SWOT Analysis Review
Income Idea: 2 Undervalued Drug Makers With Rising Gross Profit Margins
SciClone management to meet with Oppenheimer
Sciclone (SCLN) Names New Independent Registered Public Accounting Firm